- Home
- PNR vs ICLR Comparison
PNR vs ICLR Comparison
Compare PNR & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PNR
- ICLR
- Stock Information
- Founded
- PNR 1966
- ICLR 1990
- Country
- PNR United Kingdom
- ICLR Ireland
- Employees
- PNR N/A
- ICLR N/A
- Industry
- PNR Industrial Machinery/Components
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- PNR Industrials
- ICLR Health Care
- Exchange
- PNR Nasdaq
- ICLR Nasdaq
- Market Cap
- PNR 17.4B
- ICLR 13.7B
- IPO Year
- PNR N/A
- ICLR 1998
- Fundamental
- Price
- PNR $112.11
- ICLR $178.53
- Analyst Decision
- PNR Buy
- ICLR Buy
- Analyst Count
- PNR 15
- ICLR 15
- Target Price
- PNR $113.60
- ICLR $209.93
- AVG Volume (30 Days)
- PNR 1.0M
- ICLR 1.0M
- Earning Date
- PNR 10-21-2025
- ICLR 10-22-2025
- Dividend Yield
- PNR 0.91%
- ICLR N/A
- EPS Growth
- PNR N/A
- ICLR 13.11
- EPS
- PNR 3.66
- ICLR 9.73
- Revenue
- PNR $4,099,800,000.00
- ICLR $8,089,820,000.00
- Revenue This Year
- PNR $2.45
- ICLR N/A
- Revenue Next Year
- PNR $3.66
- ICLR $1.73
- P/E Ratio
- PNR $29.89
- ICLR $17.78
- Revenue Growth
- PNR N/A
- ICLR N/A
- 52 Week Low
- PNR $74.25
- ICLR $125.10
- 52 Week High
- PNR $112.91
- ICLR $310.54
- Technical
- Relative Strength Index (RSI)
- PNR 60.17
- ICLR 56.52
- Support Level
- PNR $108.83
- ICLR $164.00
- Resistance Level
- PNR $112.91
- ICLR $177.00
- Average True Range (ATR)
- PNR 2.23
- ICLR 6.80
- MACD
- PNR 0.03
- ICLR -0.32
- Stochastic Oscillator
- PNR 89.48
- ICLR 81.09
About PNR Pentair plc.
Pentair is a global leader in the water treatment industry, with 10,000 employees and a presence in 25 countries. Its business is organized into three segments: pool, water technologies, and flow. The company offers a wide range of water solutions, including energy-efficient swimming pool equipment, filtration solutions, and commercial and industrial pumps. Pentair generated approximately $4.1 billion in revenue in 2024.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.